Terms: = Endocrine gland cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25
154 results:
1. Comprehensive Analysis of MICALL2 Reveals Its Potential Roles in EGFR Stabilization and Ovarian cancer Cell Invasion.
Xia T; Ye F; Zhao W; Min P; Qi C; Wang Q; Zhao M; Zhang Y; Du J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203692
[TBL] [Abstract] [Full Text] [Related]
2. The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis.
Liu Y; Li Y; Wu Y; Zhao Y; Hu X; Sun C
J Ovarian Res; 2023 Nov; 16(1):219. PubMed ID: 37986114
[TBL] [Abstract] [Full Text] [Related]
3. Vav1-dependent rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression.
Zhu C; Hu H; Ma Y; Xiong S; Zhu D
Cell Biol Int; 2023 Nov; 47(11):1835-1842. PubMed ID: 37545183
[TBL] [Abstract] [Full Text] [Related]
4. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
Sun T; Gilani S; Jain D; Cai G
Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
[TBL] [Abstract] [Full Text] [Related]
5. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract] [Full Text] [Related]
6. Agent-based modeling predicts rac1 is critical for ovarian cancer metastasis.
Rivera M; Toledo-Jacobo L; Romero E; Oprea TI; Moses ME; Hudson LG; Wandinger-Ness A; Grimes MM
Mol Biol Cell; 2022 Dec; 33(14):ar138. PubMed ID: 36200848
[TBL] [Abstract] [Full Text] [Related]
7. The potential diagnostic value of rac1 immunohistochemistry in follicular thyroid carcinoma.
Agustina H; Ahyati R; Suryanti S; Hernowo BS
Malays J Pathol; 2022 Aug; 44(2):225-233. PubMed ID: 36043585
[TBL] [Abstract] [Full Text] [Related]
8. Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.
Sriramkumar S; Metcalfe TX; Lai T; Zong X; Fang F; O'Hagan HM; Nephew KP
PLoS One; 2022; 17(8):e0271584. PubMed ID: 35921335
[TBL] [Abstract] [Full Text] [Related]
9. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases.
Han L; Guo X; Du R; Guo K; Qi P; Bian H
J Ovarian Res; 2022 Jun; 15(1):75. PubMed ID: 35739532
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting rac1 in Pancreatic Ductal Adenocarcinoma.
Xi B; Lai M; Zhang W; Wang F
Ann Clin Lab Sci; 2022 Mar; 52(2):213-221. PubMed ID: 35414500
[TBL] [Abstract] [Full Text] [Related]
11. KRAS
Hobbs GA; Der CJ
Subcell Biochem; 2022; 98():205-221. PubMed ID: 35378710
[TBL] [Abstract] [Full Text] [Related]
12. Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic cancer Stromal Heterogeneity.
Ganguly K; Cox JL; Ghersi D; Grandgenett PM; Hollingsworth MA; Jain M; Kumar S; Batra SK
Gastroenterology; 2022 Jun; 162(7):2032-2046.e12. PubMed ID: 35219699
[TBL] [Abstract] [Full Text] [Related]
13. Ovarian cancer G protein-coupled receptor 1 inhibits A549 cells migration through casein kinase 2α intronless gene and neutral endopeptidase.
Sharma AL; Meitei PM; Machathoibi TC; Singh NT; Singh TR; Singh LS
BMC Cancer; 2022 Feb; 22(1):143. PubMed ID: 35123428
[TBL] [Abstract] [Full Text] [Related]
14. Disruption of FDPS/rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling.
Seshacharyulu P; Halder S; Nimmakayala R; Rachagani S; Chaudhary S; Atri P; Chirravuri-Venkata R; Ouellette MM; Carmicheal J; Gautam SK; Vengoji R; Wang S; Li S; Smith L; Talmon GA; Klute K; Ly Q; Reames BN; Grem JL; Berim L; Padussis JC; Kaur S; Kumar S; Ponnusamy MP; Jain M; Lin C; Batra SK
EBioMedicine; 2022 Jan; 75():103772. PubMed ID: 34971971
[TBL] [Abstract] [Full Text] [Related]
15. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract] [Full Text] [Related]
16. Mechanical Stress Signaling in Pancreatic cancer Cells Triggers p38 MAPK- and JNK-Dependent Cytoskeleton Remodeling and Promotes Cell Migration via rac1/cdc42/Myosin II.
Kalli M; Li R; Mills GB; Stylianopoulos T; Zervantonakis IK
Mol Cancer Res; 2022 Mar; 20(3):485-497. PubMed ID: 34782370
[TBL] [Abstract] [Full Text] [Related]
17. PD-1/PD-L1-Associated Immunoarchitectural Patterns Stratify Pancreatic cancer Patients into Prognostic/Predictive Subgroups.
Karamitopoulou E; Andreou A; Pahud de Mortanges A; Tinguely M; Gloor B; Perren A
Cancer Immunol Res; 2021 Dec; 9(12):1439-1450. PubMed ID: 34526323
[TBL] [Abstract] [Full Text] [Related]
18. Linoleic and oleic acids enhance cell migration by altering the dynamics of microtubules and the remodeling of the actin cytoskeleton at the leading edge.
Masner M; Lujea N; Bisbal M; Acosta C; Kunda P
Sci Rep; 2021 Jul; 11(1):14984. PubMed ID: 34294745
[TBL] [Abstract] [Full Text] [Related]
19. Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.
Waters AM; Khatib TO; Papke B; Goodwin CM; Hobbs GA; Diehl JN; Yang R; Edwards AC; Walsh KH; Sulahian R; McFarland JM; Kapner KS; Gilbert TSK; Stalnecker CA; Javaid S; Barkovskaya A; Grover KR; Hibshman PS; Blake DR; Schaefer A; Nowak KM; Klomp JE; Hayes TK; Kassner M; Tang N; Tanaseichuk O; Chen K; Zhou Y; Kalkat M; Herring LE; Graves LM; Penn LZ; Yin HH; Aguirre AJ; Hahn WC; Cox AD; Der CJ
Cell Rep; 2021 Jun; 35(13):109291. PubMed ID: 34192548
[TBL] [Abstract] [Full Text] [Related]
20. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
[TBL] [Abstract] [Full Text] [Related]
[Next]
